These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35522166)

  • 1. Still seeking balance in opioid management for acute sickle cell disease pain.
    Fasipe TA; Hulbert ML
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29741. PubMed ID: 35522166
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?
    Oni MO; Archer NM
    Am J Hematol; 2023 Apr; 98(4):564-565. PubMed ID: 36746630
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Stehouwer N; Edge P; Katie Park B; Piccone C; Little J
    Am J Hematol; 2017 Apr; 92(4):E40-E42. PubMed ID: 28066934
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid utilization patterns in United States individuals with sickle cell disease.
    Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C
    Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating palliative care and emergency medicine for optimal management of sickle cell pain in the wake of the United States opioid epidemic.
    Effiong A; Kumari P
    Ann Palliat Med; 2018 Apr; 7(2):274-276. PubMed ID: 29307211
    [No Abstract]   [Full Text] [Related]  

  • 8. Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
    Nobrega R; Carullo V; Thein SL; Quezado ZMN
    Expert Rev Hematol; 2022 Oct; 15(10):887-891. PubMed ID: 36191299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
    Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F
    Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary for Patients: Treating Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department.
    Ann Intern Med; 2021 Sep; 174(9):I14. PubMed ID: 34224269
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease.
    Glassberg JA; Tanabe P; Chow A; Harper K; Haywood C; DeBaun MR; Richardson LD
    Ann Emerg Med; 2013 Oct; 62(4):293-302.e10. PubMed ID: 23561465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis.
    Brousseau DC; Alpern ER; Chamberlain JM; Ellison AM; Bajaj L; Cohen DM; Hariharan S; Cook LJ; Harding M; Panepinto J;
    Ann Emerg Med; 2020 Sep; 76(3S):S6-S11. PubMed ID: 32928464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a dedicated day hospital for management of acute sickle cell pain.
    Adewoye AH; Nolan V; McMahon L; Ma Q; Steinberg MH
    Haematologica; 2007 Jun; 92(6):854-5. PubMed ID: 17550862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell anemia and pain: will data prevail over beliefs?
    Payne R
    Ann Emerg Med; 2009 May; 53(5):596-7. PubMed ID: 19380037
    [No Abstract]   [Full Text] [Related]  

  • 19. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.
    Carullo V; Morrone K; Weiss M; Choi J; Gao Q; Pisharoty S; Moody K; Manwani D
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29665. PubMed ID: 35294090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Complication of Sickle Cell Anemia.
    Surapaneni PK; Mills K; Renelus BD
    Gastroenterology; 2021 Jul; 161(1):45-46. PubMed ID: 33221401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.